Treprostinil Sodium Articles
Sandoz challenges United Thera’s Remodulin patents
6 February 2012
United Thera' earnings soar 74% in 3rd qtr
12 November 2007
25 new drugs get AIFA coverage in Italy
6 November 2006
United Thera: EU MRP ends for Remodulin
22 August 2005
Remodulin gets French OK
14 March 2005
Remodulin cleared in Australia for PAH
31 May 2004
United Thera files sNDA for Remodulin
9 February 2004
Approval of Remodulin in France delayed
5 January 2004
Remodulin Swiss approval on track
22 December 2003
United Therapeutics' Remodulin rejected for approval by France
29 September 2003
United Therapeutics to develop new form of Remodulin
21 July 2003
Actelion
19 August 2002
Remodulin an alternative for Flolan patients
3 June 2002
Remodulin to get fast-track review in Canada
25 February 2002
United gets tentative OK for Remodulin
18 February 2002
United's beraprost disappoints in Ph III
16 October 2001
United's Remodulin set for US approval
14 August 2001
Rival firms face FDA panel for PAH drugs
10 August 2001
United withdraws Remodulin file ahead of FDA meeting
2 August 2001
UT's Remodulin up for FDA review
4 July 2001
United on track with Ph III beraprost trial
28 February 2001
United files for UT-15 approval in Europe
6 February 2001
Showing 1-29 of 29 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
